LungVax, the world’s first vaccine against lung cancer
This work is the result of a research group at the University of Oxford, the Francis Crick Institute, in collaboration with University College London, which has developed a new vaccine, LungVax, the world’s first vaccine against lung cancer . It is designed specifically to prevent lung cancer in people at high risk.
The development of this vaccine builds on the development of AstraZeneca’s COVID-19 vaccine, which successfully delivered the genetic material of the virus via a vector directly into the body. Introduce recipients to the vaccine that leads to immunity.
This is where the idea of developing a vaccine capable of fighting cancer was born. Normally, cancer arises from cells or genes in our body that have changed. Before it divides and spreads within the body until it causes death. If we can stop this process, we may be able to fight cancer too.
To this end, they created LungVax by exploiting Neoantigens, proteins that appear on the surface of cells that have DNA mutations that cause lung cancer. But this protein is basically harmless. The research team then used the adenoviral vector technique to induce an immune response to this protein.
When stimulated by the vaccine, this type of protein is harmful to the body. This occurs when cells in the body begin to mutate. The immune system responds immediately and eliminates these foreign cells. Helps stop the formation and spread of cancer early. This will help prevent lung cancer eventually.
The research team predicts that LungVax will have a global effect in preventing lung cancer in more than 90% of patients, significantly reducing the number of lung cancer cases worldwide. It is beneficial both for the patient, for the people around him, and for the public health system. who are experiencing increasing problems with lung cancer
The discovery of this type of vaccine could therefore revolutionize the field of cancer and long-term treatment of lung cancer.
The LungVax development project is currently in the testing phase and preparing to enter clinical trials. It may take some time to verify performance, so it may not be available for very quick use. However, the research team confirmed that Vaccines only help prevent the possibility of developing cancer in the early stages. The best response is still to avoid exposure to airborne carcinogens as before.
Therefore, we still urgently need to reduce and control dust costs. To prevent people’s health from worsening.
Origin
#LungVax #worlds #viral #vector #vaccine #prevent #lung #cancer
